| Baseline metabolic tumor volume predicts outcome in high–tumor-burden follicular lymphoma: a pooled analysis of three multicenter studies M Meignan, AS Cottereau, A Versari, L Chartier, J Dupuis, S Boussetta, ... Journal of Clinical Oncology 34 (30), 3618-3626, 2016 | 314 | 2016 |
| A guide to ComBat harmonization of imaging biomarkers in multicenter studies F Orlhac, JJ Eertink, AS Cottereau, JM Zijlstra, C Thieblemont, M Meignan, ... Journal of Nuclear Medicine 63 (2), 172-179, 2022 | 204 | 2022 |
| Molecular profile and FDG-PET/CT total metabolic tumor volume improve risk classification at diagnosis for patients with diffuse large B-cell lymphoma AS Cottereau, H Lanic, S Mareschal, M Meignan, P Vera, H Tilly, F Jardin, ... Clinical Cancer Research 22 (15), 3801-3809, 2016 | 197 | 2016 |
| Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial AS Cottereau, A Versari, A Loft, O Casasnovas, M Bellei, R Ricci, S Bardet, ... Blood, The Journal of the American Society of Hematology 131 (13), 1456-1463, 2018 | 177 | 2018 |
| High total metabolic tumor volume at baseline predicts survival independent of response to therapy L Vercellino, AS Cottereau, O Casasnovas, H Tilly, P Feugier, L Chartier, ... Blood, The Journal of the American Society of Hematology 135 (16), 1396-1405, 2020 | 160 | 2020 |
| 18F-FDG PET dissemination features in diffuse large B-cell lymphoma are predictive of outcome AS Cottereau, C Nioche, AS Dirand, J Clerc, F Morschhauser, ... Journal of Nuclear Medicine 61 (1), 40-45, 2020 | 138 | 2020 |
| Risk stratification in diffuse large B-cell lymphoma using lesion dissemination and metabolic tumor burden calculated from baseline PET/CT AS Cottereau, M Meignan, C Nioche, N Capobianco, J Clerc, L Chartier, ... Annals of Oncology 32 (3), 404-411, 2021 | 124 | 2021 |
| Deep-learning 18F-FDG uptake classification enables total metabolic tumor volume estimation in diffuse large B-cell lymphoma N Capobianco, M Meignan, AS Cottereau, L Vercellino, L Sibille, ... Journal of Nuclear medicine 62 (1), 30-36, 2021 | 112 | 2021 |
| Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL) AS Cottereau, S Becker, F Broussais, O Casasnovas, S Kanoun, ... Annals of Oncology 27 (4), 719-724, 2016 | 108 | 2016 |
| MFN2-associated lipomatosis: clinical spectrum and impact on adipose tissue E Capel, C Vatier, P Cervera, T Stojkovic, E Disse, AS Cottereau, ... Journal of clinical lipidology 12 (6), 1420-1435, 2018 | 68 | 2018 |
| Baseline total metabolic tumor volume measured with fixed or different adaptive thresholding methods equally predicts outcome in peripheral T cell lymphoma AS Cottereau, S Hapdey, L Chartier, R Modzelewski, O Casasnovas, E Itti, ... Journal of Nuclear Medicine 58 (2), 276-281, 2017 | 64 | 2017 |
| A phase II study of the oral JAK1/JAK2 inhibitor ruxolitinib in advanced relapsed/refractory Hodgkin lymphoma E Van Den Neste, M André, T Gastinne, A Stamatoullas, C Haioun, ... haematologica 103 (5), 840, 2018 | 61 | 2018 |
| Predictive value of PET response combined with baseline metabolic tumor volume in peripheral T-cell lymphoma patients AS Cottereau, TC El-Galaly, S Becker, F Broussais, LJ Petersen, ... Journal of Nuclear Medicine 59 (4), 589-595, 2018 | 59 | 2018 |
| Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma F Lemonnier, V Safar, A Beldi-Ferchiou, AS Cottereau, E Bachy, ... Blood advances 5 (2), 539-548, 2021 | 56 | 2021 |
| Indications of peptide receptor radionuclide therapy (PRRT) in gastroenteropancreatic and pulmonary neuroendocrine tumors: an updated review B Camus, AS Cottereau, LJ Palmieri, S Dermine, F Tenenbaum, ... Journal of clinical medicine 10 (6), 1267, 2021 | 49 | 2021 |
| Early Phase 99Tc-HMDP Scintigraphy for the Diagnosis and Typing of Cardiac Amyloidosis A Galat, A Van der Gucht, A Guellich, D Bodez, AS Cottereau, ... JACC: Cardiovascular Imaging 10 (5), 601-603, 2017 | 42 | 2017 |
| 18F-FDG PET maximum-intensity projections and artificial intelligence: a win-win combination to easily measure prognostic biomarkers in DLBCL patients KB Girum, L Rebaud, AS Cottereau, M Meignan, J Clerc, L Vercellino, ... Journal of Nuclear Medicine 63 (12), 1925-1932, 2022 | 39 | 2022 |
| The role of interventional radiology for the treatment of hepatic metastases from neuroendocrine tumor: an updated review M Barat, AS Cottereau, A Kedra, S Dermine, LJ Palmieri, R Coriat, ... Journal of clinical medicine 9 (7), 2302, 2020 | 37 | 2020 |
| Total tumor burden in lymphoma–an evolving strong prognostic parameter M Meignan, AS Cottereau, L Specht, NG Mikhaeel The British journal of radiology 94 (1127), 20210448, 2021 | 34 | 2021 |
| Redifferentiating Effect of Larotrectinib in NTRK-Rearranged Advanced Radioactive-Iodine Refractory Thyroid Cancer L Groussin, H Theodon, L Bessiene, L Bricaire, F Bonnet-Serrano, ... Thyroid 32 (5), 594-598, 2022 | 33 | 2022 |
